This review finds that topical corticosteroids and systemic corticosteroids are the mainstays of initial treatment for bullous pemphigoid and pemphigus diseases. Additional immunomodulatory therapies such as methotrexate, azathioprine and mycophenolatmofetil should be added early during treatment to minimize the adverse effects of chronic corticosteroid therapy and to augment improvement in the disease. Rituximab is a first-line immunomodulatory treatment for moderate to severe pemphigus disease.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[bullous skin
4
skin diseases]
4
diseases] review
4
review finds
4
finds topical
4
topical corticosteroids
4
corticosteroids systemic
4
systemic corticosteroids
4
corticosteroids mainstays
4
mainstays initial
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!